Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management that have demonstrated significant weight loss effects
Beyond visual inspection, if you notice reduced appetite suppression, diminished weight loss results, or an unexpected increase in hunger after several weeks of treatment, improper storage of previous doses may be contributing
The frequency of these labs will depend on your health risks, how you respond to treatment, and any potential side effects
These medications mimic natural gut hormones (GLP-1 and GIP) that regulate hunger, blood sugar, and digestion
For individuals with Type 2 diabetes, semaglutide can improve blood sugar levels by helping the pancreas release insulin only when blood sugar is high
Q: Will Tretinoin make my skin more sensitive to the sun